Tempus AI Inc.
31.84
-0.50 (-1.55%)
At close: Jan 14, 2025, 3:59 PM
32.17
1.05%
After-hours Jan 14, 2025, 07:59 PM EST
undefined%
Bid 31.92
Market Cap 4.85B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -5.16
PE Ratio (ttm) -6.17
Forward PE n/a
Analyst Buy
Ask 32.2
Volume 3,841,908
Avg. Volume (20D) 2,550,296
Open 33.10
Previous Close 32.34
Day's Range 31.66 - 34.62
52-Week Range 22.89 - 79.49
Beta undefined

About TEM

Tempus AI, Inc operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company also offers Insights, a license library of linked clinical, molecular, and imaging de-iden...

Sector Healthcare
IPO Date Mar 28, 2012
Employees 2,300
Stock Exchange NASDAQ
Ticker Symbol TEM

Analyst Forecast

According to 11 analyst ratings, the average rating for TEM stock is "Buy." The 12-month stock price forecast is $55, which is an increase of 72.77% from the latest price.

Buy 72.73%
Hold 27.27%
Sell 0.00%
Stock Forecasts
1 day ago · Source
-13.81%
Tempus AI shares are trading lower after the compa... Unlock content with Pro Subscription
2 months ago · Source
-10.1%
Tempus AI shares are trading lower after the company reported mixed Q3 financial results. Also, the company announced it entered into an agreement to acquire Ambry Genetics.